Avita Medical Inc.
RCEL Healthcare Medical Devices
Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 17.8%, EPS grew 33.8%, free cash flow grew 66.5% and total debt rose 10.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow RCEL
Avita Medical Inc. (RCEL) EV/Sales
As of 16 October 2026, Avita Medical Inc. (RCEL) trades at a EV/Sales of 1.3×. Over the past ten years it has ranged from −7.2× (June 2022) to 1.3× (October 2026); the current reading is higher than 100% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.0× | 167.64% |
| FY2024 | 0.4× | — |
| FY2023 | −0.6× | — |
| FY2022 | −2.0× | — |
| FY2021 | −5.0× | — |
| FY2021 | −2.8× | — |
| FY2020 | −2.1× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.1× | 0.93% |
| Mar 2026 | 1.1× | 10.02% |
| Dec 2025 | 1.0× | 5.89% |
| Sep 2025 | 0.9× | (6.38%) |
| 23 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| OFIX ORTHOFIX MEDICAL INC. compare | 0.6× |
| VMD Viemed Healthcare, Inc. compare | 1.2× |
| RCEL Avita Medical Inc. | 1.3× |
| TMCI Treace Medical Concepts, Inc. compare | 1.3× |
| INFU InfuSystems Holdings, Inc. compare | 2.0× |
| SI Shoulder Innovations, Inc. compare | 4.8× |
| CLPT ClearPoint Neuro, Inc. compare | 7.0× |
| CV CapsoVision, Inc. compare | 22.8× |
| QSI Quantum-Si Incorporated compare | 82.4× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)